References
- European Association for the Study of the Liver; European Organisation for Research and Treatment of Cancer . EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J. Hepatol.56(4), 908–943 (2012).
- Santi V , BuccioneD, Di MicoliAet al. The changing scenario of hepatocellular carcinoma over the last two decades in Italy. J. Hepatol.56(2), 397–405 (2012).
- Germani G , PleguezueloM, GurusamyK, MeyerT, IsgròG, BurroughsAK. Clinical outcomes of radiofrequency ablation, percutaneous alcohol and acetic acid injection for hepatocelullar carcinoma: a meta-analysis. J. Hepatol.5(3), 380–388 (2010).
- Di Costanzo GG , TortoraR, D'AdamoGet al. Radiofrequency ablation versus laser ablation for the treatment of small hepatocellular carcinoma in cirrhosis: a randomized trial. J. Gastroenterol. Hepatol.30(3), 559–565 (2015).
- Zhang L , WangN, ShenQ, ChengW, QianGJ. Therapeutic efficacy of percutaneous radiofrequency ablation versus microwave ablation for hepatocellular carcinoma. PLoS ONE8(10), e76119 (2013).
- Wang C , WangH, YangWet al. Multicenter randomized controlled trial of percutaneous cryoablation versus radiofrequency ablation in hepatocellular carcinoma. Hepatology61(5), 1579–1590 (2015).
- Shiina S , TateishiR, AranoTet al. Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors. Am. J. Gastroenterol.107(4), 569–577 (2012).
- Francica G , SavianoA, De SioIet al. Long-term effectiveness of radiofrequency ablation for solitary small hepatocellular carcinoma: a retrospective analysis of 363 patients. Dig. Liver Dis.45(4), 336–341 (2013).
- Pompili M , FrancicaG, PonzianiFR, IezziR, AvolioAW. Bridging and downstaging treatments for hepatocellular carcinoma in patients on the waiting list for liver transplantation. World J. Gastroenterol.19(43), 7515–7530 (2013).
- Chen MS , LiJQ, ZhengYet al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann. Surg.243(3), 321–328 (2006).
- Feng K , YanJ, LiXet al. A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma. J. Hepatol.57(4), 794–802 (2012).
- Huang J , YanL, ChengZet al. A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria. Ann. Surg.252(6), 903–912 (2010).
- Pompili M , SavianoA, de MatthaeisNet al. Long-term effectiveness of resection and radiofrequency ablation for single hepatocellular carcinoma ≤3 cm. Results of a multicenter Italian survey. J. Hepatol.59(1), 89–97 (2013).
- Liu PH , HsuCY, HsiaCYet al. Surgical resection versus radiofrequency ablation for single hepatocellular carcinoma ≤ 2 cm in a propensity score model. Ann. Surg. (2015) ( Epub ahead of print).
- Kang TW , KimJM, RhimHet al. Small hepatocellular carcinoma: radiofrequency ablation versus non anatomic resection – propensity score analyses of long-term outcomes. Radiology275(3), 908–919 (2015).
- Cucchetti A , PiscagliaF, CesconMet al. Cost–effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma. J. Hepatol.59(2), 300–307 (2013).
- Wang Y , LuoQ, LiY, DengS, WeiS, LiX. Radiofrequency ablation versus hepatic resection for small hepatocellular carcinomas: a meta-analysis of randomized and nonrandomized controlled trials. PLoS ONE9(1), e84484 (2014).
- Nakayama H , TakayamaT. Role of surgical resection for hepatocellular carcinoma based on Japanese clinical guidelines for hepatocellular carcinoma. World J. Hepatol.7(2), 261–269 (2015).
- Mendiratta-Lala M , BrookOR, MidkiffBDet al. Quality initiatives: strategies for anticipating and reducing complications and treatment failures in hepatic radiofrequency ablation. Radiographics30(4), 1107–1122 (2010).
- Roayaie S , ObeidatK, SpositoCet al. Resection of hepatocellular cancer ≤2 cm: results from two Western centers. Hepatology57(4), 1426–1435 (2013).